Bezalip/Bezalip Retard

Bezalip/Bezalip Retard

bezafibrate

Manufacturer:

Teva

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Bezafibrate
Indications/Uses
Primary hyperlipidemia types IIa, IIb, III, IV & V. Secondary hyperlipidemia eg, severe hypertriglyceridemia.
Dosage/Direction for Use
Bezalip 1 tab tds, may be reduced to 1 tab bd in case of good therapeutic response especially in hypertriglyceridemia. Bezalip Retard 1 tab daily. Limited renal function, use only Bezalip.
Administration
Should be taken with food: Swallow whole, do not chew/crush.
Contraindications
Liver diseases (except fatty liver), gallbladder diseases w/ or w/o cholelithiasis. Severe renal impairment (serum creatinine >6 mg/100 mL or CrCl <15 mL/min for Bezalip or >1.6 mg/100 mL or 136 micromol/L for Bezalip Retard). Nephrotic syndrome. Patients undergoing dialysis. Combination therapy w/ HMG-CoA reductase inhibitors in patients w/ predisposing factors for myopathy. Photoallergic or phototoxic reactions to fibrates. Pregnancy & lactation. Elderly (Bezalip Retard).
Special Precautions
Discontinue if adequate response has not been achieved w/ in 3-4 mth. Concurrent treatment w/ oestrogens or oestrogen-containing OC, HMG-CoA reductase inhibitors, cholestyramine. Impaired renal function, hypoalbuminaemia. Childn.
Adverse Reactions
Decreased appetite, transient GI disturbances, myopathy, rhabdomyolysis.
Drug Interactions
Decreased absorption by cholestyramine. Potentiates action of coumarin anticoagulants, sulfonylureas & insulin. Immunosuppressants, MAOI or perhexiline hydrogen maleate, HMG-CoA reductase inhibitors.
ATC Classification
C10AB02 - bezafibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Bezalip Retard modified-release tab 400 mg
Packing/Price
100's
Form
Bezalip tab 200 mg
Packing/Price
100's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in